Back to search

Article

BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children

2022-05-21

Abstract excerpt

Currently available mRNA vaccines are extremely safe and effective to prevent severe SARS-CoV-2 infections. However, the emergence of novel variants of concerns has highlighted the importance of high population-based vaccine rates to effectively suppress viral transmission and breakthrough infections. While initially left out from vaccine efforts, children have become one of the most affected age groups and are ke...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
428095eb-4ee5-516e-9e02-9a65d335cdeb
DOI
10.1101/2022.05.18.22275283
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in childrenDOI 10.1101/2022.05.18.22275283
Select a neighboring publication to make it the new centre.